{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T13:04:33Z","timestamp":1705583073097},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1995,6,1]],"date-time":"1995-06-01T00:00:00Z","timestamp":801964800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[1995,6]]},"DOI":"10.1007\/bf02347513","type":"journal-article","created":{"date-parts":[[2006,3,15]],"date-time":"2006-03-15T17:46:28Z","timestamp":1142444788000},"page":"367-371","source":"Crossref","is-referenced-by-count":9,"title":["Interferon treatment of chronic hepatitis C in patients with hemophilia or von Willebrand's disease in Japan"],"prefix":"10.1007","volume":"30","author":[{"given":"Masahide","family":"Yoshikawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyuki","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Yoshiji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takemi","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroo","family":"Imazu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiya","family":"Nakanani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinobu","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeki","family":"Kuriyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Yamao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Uemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Takaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadasu","family":"Tsujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Midori","family":"Shima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02347513_CR1","first-page":"1495","volume":"I","author":"CM Hay","year":"1985","unstructured":"Hay CM, Preston FE, Triger DR, et al. Progressive liver disease in haemophilia: An understated problem? Lancet 1985;I:1495\u20131498.","journal-title":"Lancet"},{"key":"BF02347513_CR2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/ajh.2830270103","volume":"27","author":"DL Aronson","year":"1988","unstructured":"Aronson DL. Cause of death in hemophilia A patients in the United States from 1968 to 1979. Am J Hematol 1988;27:7\u201312.","journal-title":"Am J Hematol"},{"key":"BF02347513_CR3","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/0140-6736(90)91124-S","volume":"335","author":"M Makris","year":"1990","unstructured":"Makris M, Preston FE, Triger DR, et al. Hepatitis C antibody and chronic liver disease in haemophilia. Lancet 1990;335:1117\u20131119.","journal-title":"Lancet"},{"key":"BF02347513_CR4","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1182\/blood.V76.1.254.254","volume":"76","author":"DB Brettler","year":"1990","unstructured":"Brettler DB, Alter HJ, Dienstag JL, et al. Prevalence of hepatitis C virus antibody in a cohort of hemophilia patients. Blood 1990;76:254\u2013256.","journal-title":"Blood"},{"key":"BF02347513_CR5","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1365-2141.1991.tb08064.x","volume":"79","author":"RS Tedder","year":"1991","unstructured":"Tedder RS, Briggs M, Ring C, et al. Hepatitis C antibody and viremia prevalence in adults with severe haemophilia. Br J Haematol 1991;79:512\u2013515.","journal-title":"Br J Haematol"},{"key":"BF02347513_CR6","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1056\/NEJM198911303212203","volume":"321","author":"GL Davis","year":"1989","unstructured":"Davis GL, Balart LA, Schiff ER, et al. Treatment of chronic hepatitis C with recombinant interferon alpha: A multicenter randomized, controlled trial. N Engl J Med 1989;321:1501\u20131506.","journal-title":"N Engl J Med"},{"key":"BF02347513_CR7","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM198911303212204","volume":"321","author":"AM Bisceglie Di","year":"1989","unstructured":"Di Bisceglie AM, Martin P, Kassianides C, et al. Recombinant interferon-alpha therapy for chronic hepatitis C: A randomized, double-blind, placebo-controlled trial. N Engl J Med 1989;321: 1506\u20131501.","journal-title":"N Engl J Med"},{"key":"BF02347513_CR8","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/hep.1840130606","volume":"13","author":"K Chayama","year":"1991","unstructured":"Chayama K, Saitoh S, Arase Y, et al. Effect of interferon administration on serum hepatitis C virus RNA in patients with chronic hepatitis C. Hepatology 1991;13:1040\u20131043.","journal-title":"Hepatology"},{"key":"BF02347513_CR9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/hep.1840150108","volume":"15","author":"H Hagiwara","year":"1992","unstructured":"Hagiwara H, Hayashi N, Mita E, et al. Detection of hepatitis C virus RNA in serum of patients with chronic hepatitis C treated with interferon-alpha. Hepatology 1992;15:37\u201341.","journal-title":"Hepatology"},{"key":"BF02347513_CR10","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/hep.1840160203","volume":"16","author":"K Yoshioka","year":"1992","unstructured":"Yoshioka K, Kakumu S, Wakita T, et al. Detection of hepatitis C virus by polymerase chain reaction and response to interferon therapy: Relationship to genotypes of hepatitis C virus. Hepatology 1992;16:293\u2013299.","journal-title":"Hepatology"},{"key":"BF02347513_CR11","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0928-4346(93)90005-Z","volume":"1","author":"S Takase","year":"1993","unstructured":"Takase S, Takada N, Sawada M, et al. Effects of interferon for chronic type C liver diseases with different hepatitis C virus genotypes: A cooperative study in three hospitals. Int Hepatol Commun 1993;1:321\u2013325.","journal-title":"Int Hepatol Commun"},{"key":"BF02347513_CR12","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1440-1746.1993.tb01648.x","volume":"8","author":"A Tsubota","year":"1993","unstructured":"Tsubota A, Chayama K, Arase Y, et al. Factors useful in predicting the response to interferon therapy in chronic hepatitis C. J Gastroenterol Hepatol 1993;8:535\u2013539.","journal-title":"J Gastroenterol Hepatol"},{"key":"BF02347513_CR13","first-page":"201","volume":"27","author":"M Yano","year":"1993","unstructured":"Yano M, Yatsuhashi H, Koga M. HCV-RNA levels and anti-HCV levels (in Japanese). Kan-Tan-Sui 1993;27:201\u2013206.","journal-title":"Kan-Tan-Sui"},{"key":"BF02347513_CR14","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/0140-6736(93)90635-T","volume":"341","author":"JYN Lan","year":"1993","unstructured":"Lan JYN, Davis GL, Kniffen J, et al. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 1993;341:1501\u20131504.","journal-title":"Lancet"},{"key":"BF02347513_CR15","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1182\/blood.V78.7.1672.1672","volume":"78","author":"M Makris","year":"1991","unstructured":"Makris M, Preston FE, Triger DR, et al. A randomized controlled trial of recombinant interferon-alpha in chronic hepatitis C in hemophiliacs. Blood 1991;78:1672\u20131677.","journal-title":"Blood"},{"key":"BF02347513_CR16","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3109\/00365529208999943","volume":"27","author":"D Bresters","year":"1992","unstructured":"Bresters D, Mauser-Bunschoten EP, Cuypers HTM, et al. Disappearance of hepatitis C virus RNA in plasma during interferon alpha-2b treatment in hemophilia patients. Scand J Gastroenterol 1992;27:166\u2013168.","journal-title":"Scand J Gastroenterol"},{"key":"BF02347513_CR17","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0140-6736(68)90710-1","volume":"II","author":"P Groote","year":"1968","unstructured":"Groote P, Desmet VJ, Gedigk P, et al. A classification of chronic hepatitis. Lancet 1968;II:626\u2013628.","journal-title":"Lancet"},{"key":"BF02347513_CR18","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/0006-291X(90)90494-8","volume":"170","author":"N Enomoto","year":"1990","unstructured":"Enomoto N, Takada A, Nakao T, et al. There are two major types of hepatitis C virus in Japan. Biochem Biophys Res Commun 1990;170:1021\u20131025.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF02347513_CR19","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1099\/0022-1317-73-3-673","volume":"73","author":"H Okamoto","year":"1992","unstructured":"Okamoto H, Sugiyama Y, Okada S, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: Application to clinical surveys and tracing infectious sources. J Gen Virol 1992;73:637\u2013679.","journal-title":"J Gen Virol"},{"key":"BF02347513_CR20","first-page":"214","volume":"37","author":"M Kinoshita","year":"1993","unstructured":"Kinoshita M, Hadama T, Edotani M, et al. Competitive assay for human hepatitis C virus RNA (in Japanese). Rinshokennsa (J Med Technol) 1993;37:214\u2013218.","journal-title":"Rinshokennsa (J Med Technol)"},{"key":"BF02347513_CR21","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1182\/blood.V81.7.1898.1898","volume":"81","author":"M Makris","year":"1993","unstructured":"Makris M, Garson JA, Ring CJA, et al. Hepatitis C viral RNA in clotting factor concentrates and the development of hepatitis in recipients. Blood 1993;81:1898\u20131902.","journal-title":"Blood"},{"issue":"Suppl","key":"BF02347513_CR22","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1136\/gut.34.2_Suppl.S124","volume":"34","author":"D Bresters","year":"1993","unstructured":"Bresters D, Mauser-Bunschoten EP, Cuypers HTM, et al. Long-term treatment of chronic hepatitis C with interferon alpha-2b: Disappearance of HCV-RNA in a pilot study of eight haemophilia patients. Gut 1993;34(Suppl):S124-S125.","journal-title":"Gut"},{"key":"BF02347513_CR23","first-page":"230","volume":"43","author":"T Uchida","year":"1993","unstructured":"Uchida T, Taira M, Shikata T, et al. Histological difference between complete responders and non-responders to interferon therapy in the livers of patients with chronic hepatitis C. Acta Pathol Jpn 1993;43:230\u2013236.","journal-title":"Acta Pathol Jpn"},{"key":"BF02347513_CR24","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0168-8278(05)80205-3","volume":"17","author":"N Takada","year":"1993","unstructured":"Takada N, Takase S, Takada A, et al. Differences in the hepatitis C virus genotypes in different countries. J Hepatol 1993;17:277\u2013283.","journal-title":"J Hepatol"},{"key":"BF02347513_CR25","doi-asserted-by":"crossref","first-page":"9580","DOI":"10.1073\/pnas.85.24.9580","volume":"85","author":"RL Willey","year":"1988","unstructured":"Willey RL, Bonifacino JS, Potts BJ, et al. Biosynthesis, cleavage, and degradation of the human immunodeficiency virus type 1 envelope glycoprotein gp 160. Proc Natl Acad Sci USA 1988;85:9580\u20139584.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02347513_CR26","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1126\/science.2470148","volume":"244","author":"G Poli","year":"1989","unstructured":"Poli G, Orenstein JM, Kinter A, et al. Interferon but not AZT suppresses HIV expression in chronically infected cell lines. Science 1989;244:575\u2013577.","journal-title":"Science"},{"key":"BF02347513_CR27","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/0016-5085(89)90405-8","volume":"97","author":"P Martin","year":"1989","unstructured":"Martin P, Di Bisceglie AM, Kassianides C, et al. Rapidly progressive non-A, non-B hepatitis patients with human immuno-deficiency virus infection. Gastroenterology 1989;97:1559\u20131561.","journal-title":"Gastroenterology"},{"key":"BF02347513_CR28","first-page":"602","volume":"6","author":"ME Eyster","year":"1993","unstructured":"Eyster ME, Diamondstone LS, Lien JM, et al. Natural history of hepatitis C virus infection in multitransfused hemophiliacs: Effects of coinfection with human immunodeficiency virus. J Acqu Immune Defic Syndr 1993;6:602\u2013610.","journal-title":"J Acqu Immune Defic Syndr"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02347513.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02347513\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02347513","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T06:24:04Z","timestamp":1586759044000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02347513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,6]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1995,6]]}},"alternative-id":["BF02347513"],"URL":"https:\/\/doi.org\/10.1007\/bf02347513","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,6]]}}}